Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
5
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
san diego blog main
5
×
san diego top stories
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer immunotherapy
nonalcoholic steatohepatitis
president trump
abbvie
amgen
astrazeneca
avexis
biogen
brian kaspar
bristol-myers squibb
What
biotech
5
×
roundup
annual
attention
bio
control
days
drug
news
today
according
ahead
aiming
akcea
alzheimer’s
ambien
ambys
american
asco
assessed
attendees
august
big
busy
camp’s
cancer
cases
cash
centers
chicago
cigarettes
city
clinical
combinations
communities
community’s
conference
deadly
deal
deaths
Language
unset
Current search:
" san diego blog main "
×
" boston top stories "
×
biotech
×
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@xconomy.com
6 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More